131 related articles for article (PubMed ID: 38750780)
1. Galectin-3 in chronic kidney disease.
Bellos I; Marinaki S; Lagiou P; Benetou V
Clin Chim Acta; 2024 Jun; 559():119727. PubMed ID: 38750780
[TBL] [Abstract][Full Text] [Related]
2. Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes.
Kim AJ; Ro H; Kim H; Chang JH; Lee HH; Chung W; Jung JY
Am J Nephrol; 2021; 52(2):119-130. PubMed ID: 33725696
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.
Drechsler C; Delgado G; Wanner C; Blouin K; Pilz S; Tomaschitz A; Kleber ME; Dressel A; Willmes C; Krane V; Krämer BK; März W; Ritz E; van Gilst WH; van der Harst P; de Boer RA
J Am Soc Nephrol; 2015 Sep; 26(9):2213-21. PubMed ID: 25568176
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of galectin-3 in chronic kidney disease patients: a systematic review and meta-analysis.
Zhang T; Cao S; Yang H; Li J
Int Urol Nephrol; 2019 Jun; 51(6):1005-1011. PubMed ID: 30963453
[TBL] [Abstract][Full Text] [Related]
5. Association of serum galectin-3 levels with mortality and cardiovascular disease outcomes in hemodialysis patients: a systematic review and dose-response meta-analysis.
Bellos I; Marinaki S; Lagiou P; Benetou V
Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38519721
[TBL] [Abstract][Full Text] [Related]
6. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
7. Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study.
Liu S; Wu Q; Zhang S; Wang Z; Liu H; Teng L; Xiao P; Lu Y; Wang X; Dong C; Xiao J; Zhang J
BMC Nephrol; 2022 Jan; 23(1):5. PubMed ID: 34979958
[TBL] [Abstract][Full Text] [Related]
8. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study.
Aguilar D; Sun C; Hoogeveen RC; Nambi V; Selvin E; Matsushita K; Saeed A; McEvoy JW; Shah AM; Solomon SD; Boerwinkle E; Ballantyne CM
J Am Heart Assoc; 2020 Jul; 9(13):e015405. PubMed ID: 32573308
[TBL] [Abstract][Full Text] [Related]
9. Association of soluble suppression of tumorigenicity 2 with mortality and adverse outcomes in chronic kidney disease: a systematic review and meta-analysis.
Bellos I; Marinaki S; Lagiou P; Benetou V
Clin Exp Nephrol; 2024 Apr; ():. PubMed ID: 38678167
[TBL] [Abstract][Full Text] [Related]
10. Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5.
Hsu BG; Wang CH; Lai YH; Tsai JP
Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437403
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes.
Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
Diabetes Metab Res Rev; 2019 Feb; 35(2):e3093. PubMed ID: 30378236
[TBL] [Abstract][Full Text] [Related]
12. Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.
Rebholz CM; Selvin E; Liang M; Ballantyne CM; Hoogeveen RC; Aguilar D; McEvoy JW; Grams ME; Coresh J
Kidney Int; 2018 Jan; 93(1):252-259. PubMed ID: 28865675
[TBL] [Abstract][Full Text] [Related]
13. Association of small, dense low-density lipoprotein cholesterol and galectin-3 in patients with chronic kidney disease.
Savic J; Zeljkovic A; Bogavac-Stanojevic N; Simic-Ogrizovic S; Kravljaca M; Stosovic M; Vekic J; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z; Gojkovic T; Spasic S
Scand J Clin Lab Invest; 2014 Oct; 74(7):637-43. PubMed ID: 24958359
[TBL] [Abstract][Full Text] [Related]
14. The fibrosis marker galectin-3 and outcome in the general population.
de Boer RA; van Veldhuisen DJ; Gansevoort RT; Muller Kobold AC; van Gilst WH; Hillege HL; Bakker SJ; van der Harst P
J Intern Med; 2012 Jul; 272(1):55-64. PubMed ID: 22026577
[TBL] [Abstract][Full Text] [Related]
15. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 and Risk of Late Graft Failure in Kidney Transplant Recipients: A 10-year Prospective Cohort Study.
Sotomayor CG; Te Velde-Keyzer CA; Diepstra A; van Londen M; Pol RA; Post A; Gans ROB; Nolte IM; Slart RHJA; de Borst MH; Berger SP; Rodrigo R; Navis GJ; de Boer RA; Bakker SJL
Transplantation; 2021 May; 105(5):1106-1115. PubMed ID: 32639409
[TBL] [Abstract][Full Text] [Related]
17. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
Srivatsan V; George M; Shanmugam E
Eur J Prev Cardiol; 2015 Sep; 22(9):1096-110. PubMed ID: 25268020
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Elevated Plasma Galectin-3 for Renal Adverse Events in Dialysis Patients: A Systematic Review and Meta-Analysis.
Lu H; Shen J; Sun J; Sun J
Altern Ther Health Med; 2023 Nov; 29(8):86-91. PubMed ID: 37652423
[TBL] [Abstract][Full Text] [Related]
19. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
Seiler-Mussler S; Limbach AS; Emrich IE; Pickering JW; Roth HJ; Fliser D; Heine GH
Clin J Am Soc Nephrol; 2018 Apr; 13(4):569-576. PubMed ID: 29507005
[TBL] [Abstract][Full Text] [Related]
20. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
